SCHEMBL825897

SCHEMBL825897

CCCC#C[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL953771 0.82
SCHEMBL2393399 0.80
SCHEMBL303163 0.79 HMGCR (0.37)
SCHEMBL5845203 0.78 HMGCR (0.55)
SCHEMBL4130261 0.78 HMGCR (0.55)
SCHEMBL2395804 0.78 HMGCR (0.55)
SCHEMBL4148858 0.78 HMGCR (0.55)
SCHEMBL5845890 0.78 HMGCR (0.55)
SCHEMBL5845029 0.78 HMGCR (0.55)
SCHEMBL338644 0.78 HMGCR (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 376 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015057992-A1 BTK INHIBITORS FOR HEMATOPOIETIC MOBILIZATION IZUMI RAQUEL (US) 2015-04-23 WO claimed
EP-1790639-B1 SPIROCYCLIC COMPOUNDS AND THEIR USE AS CXCR4-ANTAGONISTS ONO PHARMACEUTICAL CO (JP) 2014-03-26 EP claimed
US-7951816-B2 Compound containing basic group and use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2011-05-31 US claimed
EP-0788511-B1 CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO (JP) 2002-12-11 EP claimed
US-20240229037-A1 SIRNA TARGETING 17Beta-HYDROXYSTEROID DEHYDROGENASE TYPE 13 AND SIRNA CONJUGATE TUOJIE BIOTECH (SHANGHAI) CO., LTD. (CN) 2024-07-11 US disclosed
US-20240209373-A1 ELONGATION OF VERY LONG CHAIN FATTY ACIDS PROTEIN 1 (ELOVL1) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF ALNYLAM PHARMACEUTICALS, INC. (US) 2024-06-27 US disclosed
US-20240200077-A1 STEAROYL-COA DESATURASE 5 (SCD5) IRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF ALNYLAM PHARMACEUTICALS, INC. (US) 2024-06-20 US disclosed
EP-4384225-A1 PEPTIDE Cancer Research Technology Limited (GB) 2024-06-19 EP disclosed
EP-4376953-A1 PEPTIDE LIGANDS FOR CNS AND OCULAR DELIVERY OF RNAI COMPOUNDS Alnylam Pharmaceuticals, Inc. (US) 2024-06-05 EP disclosed
EP-3784269-B1 INTEGRIN TARGETING LIGANDS AND USES THEREOF ARROWHEAD PHARMACEUTICALS INC (US) 2024-06-05 EP disclosed
EP-4371979-A1 FORMAMIDE DERIVATIVE AND AGRICULTURAL OR HORTICULTURAL PLANT DISEASE CONTROL AGENT Kumiai Chemical Industry Co., Ltd. (JP) 2024-05-22 EP disclosed
US-20240157333-A1 PICOSCALE THIN LAYER CHROMATOGRAPHY FOR ANALYSIS OF SINGLE CELLS AND MICROSAMPLES UNIVERSITY OF WASHINGTON (US) 2024-05-16 US disclosed
WO-1998034898-A1 PHENOXYACETIC ACID DERIVATIVES AND THEIR USE AS HERBICIDES RHONE-POULENC AGRO (FR) 1998-08-13 WO disclosed
EP-0762876-A1 A PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND/OR TREATMENT OF VIRAL INFECTIONS AND OPTIONALLY INFLAMMATIONS AS WELL AS A METHOD FOR THE TREATMENT THEREOF BERG, Kurt Frimann (DK) 1997-03-19 EP disclosed
WO-1995035103-A1 A PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND/OR TREATMENT OF VIRAL INFECTIONS AND OPTIONALLY INFLAMMATIONS AS WELL AS A METHOD FOR THE TREATMENT THEREOF BERG KURT (DK) 1995-12-28 WO disclosed
US-4438277-A Hydronaphthalene derivatives SANKYO COMPANY, LIMITED (JP) 1984-03-20 US disclosed
US-4361515-A Antihyperlipemic dihydro-ML-236B derivatives, their preparation and use SANKYO COMPANY, LIMITED (JP) 1982-11-30 US disclosed
US-4252970-A MULTISTEP PROCESS, ONE STEP IS DESULFONATION OF 6-SULFONYLNEAMINES TO FORM 5,6-DIDEOXY-5-OXONEAMINES THE UPJOHN COMPANY (US) 1981-02-24 US disclosed
US-4232148-A ANTIBACTERIAL THE UPJOHN COMPANY (US) 1980-11-04 US disclosed
US-4169197-A ANTIBIOTICS THE UPJOHN COMPANY (US) 1979-09-25 US disclosed